Product Code: TMRGL66551
The report provides revenue of the global equine supplement products market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global equine supplement products market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the equine supplement products market.
The report delves into the competitive landscape of the global equine supplement products market. Key players operating in the global equine supplement products market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global equine supplement products market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Equine Supplement Products Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Equine Supplement Products Market Analysis and Forecast, 2017-2031
- 4.5. Porter's Five Force Analysis
5. Market Outlook
- 5.1. New Product Launch
- 5.2. Key Mergers & Acquisitions
- 5.3. Equine Population Overview, by Region
- 5.4. Regulatory Scenario, by Region/globally
6. Global Equine Supplement Products Market Analysis and Forecast, by Supplement
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Supplement, 2017-2031
- 6.3.1. Proteins/Amino Acids
- 6.3.2. Vitamins
- 6.3.3. Enzymes
- 6.3.4. Electrolytes & Minerals
- 6.3.5. Others
- 6.4. Market Attractiveness Analysis, by Supplement
7. Global Equine Supplement Products Market Analysis and Forecasts, by Application
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Application, 2017-2031
- 7.3.1. Performance Enhancement/Recovery
- 7.3.2. Joint Disorder Prevention
- 7.3.3. Others
- 7.4. Market Attractiveness Analysis, by Application
8. Global Equine Supplement Products Market Analysis and Forecast, by Distribution Channel
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 8.3.1. Veterinary Hospital Pharmacies
- 8.3.2. Retail Pharmacies
- 8.3.3. Others
- 8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Equine Supplement Products Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Equine Supplement Products Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Supplement, 2017-2031
- 10.2.1. Proteins/Amino Acids
- 10.2.2. Vitamins
- 10.2.3. Enzymes
- 10.2.4. Electrolytes & Minerals
- 10.2.5. Others
- 10.3. Market Value Forecast, by Application, 2017-2031
- 10.3.1. Performance Enhancement/Recovery
- 10.3.2. Joint Disorder Prevention
- 10.3.3. Others
- 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 10.4.1. Veterinary Hospital Pharmacies
- 10.4.2. Retail Pharmacies
- 10.4.3. Others
- 10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Supplement
- 10.6.2. By Application
- 10.6.3. By Distribution Channel
- 10.6.4. By Country
11. Europe Equine Supplement Products Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Supplement, 2017-2031
- 11.2.1. Proteins/Amino Acids
- 11.2.2. Vitamins
- 11.2.3. Enzymes
- 11.2.4. Electrolytes & Minerals
- 11.2.5. Others
- 11.3. Market Value Forecast, by Application, 2017-2031
- 11.3.1. Performance Enhancement/Recovery
- 11.3.2. Joint Disorder Prevention
- 11.3.3. Others
- 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 11.4.1. Veterinary Hospital Pharmacies
- 11.4.2. Retail Pharmacies
- 11.4.3. Others
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Supplement
- 11.6.2. By Application
- 11.6.3. By Distribution Channel
- 11.6.4. By Country/Sub-region
12. Asia Pacific Equine Supplement Products Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Supplement, 2017-2031
- 12.2.1. Proteins/Amino Acids
- 12.2.2. Vitamins
- 12.2.3. Enzymes
- 12.2.4. Electrolytes & Minerals
- 12.2.5. Others
- 12.3. Market Value Forecast, by Application, 2017-2031
- 12.3.1. Performance Enhancement/Recovery
- 12.3.2. Joint Disorder Prevention
- 12.3.3. Others
- 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 12.4.1. Veterinary Hospital Pharmacies
- 12.4.2. Retail Pharmacies
- 12.4.3. Others
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Supplement
- 12.6.2. By Application
- 12.6.3. By Distribution Channel
- 12.6.4. By Country/Sub-region
13. Latin America Equine Supplement Products Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Supplement, 2017-2031
- 13.2.1. Proteins/Amino Acids
- 13.2.2. Vitamins
- 13.2.3. Enzymes
- 13.2.4. Electrolytes & Minerals
- 13.2.5. Others
- 13.3. Market Value Forecast, by Application, 2017-2031
- 13.3.1. Performance Enhancement/Recovery
- 13.3.2. Joint Disorder Prevention
- 13.3.3. Others
- 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 13.4.1. Veterinary Hospital Pharmacies
- 13.4.2. Retail Pharmacies
- 13.4.3. Others
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Supplement
- 13.6.2. By Application
- 13.6.3. By Distribution Channel
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Equine Supplement Products Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Supplement, 2017-2031
- 14.2.1. Proteins/Amino Acids
- 14.2.2. Vitamins
- 14.2.3. Enzymes
- 14.2.4. Electrolytes & Minerals
- 14.2.5. Others
- 14.3. Market Value Forecast, by Application, 2017-2031
- 14.3.1. Performance Enhancement/Recovery
- 14.3.2. Joint Disorder Prevention
- 14.3.3. Others
- 14.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 14.4.1. Veterinary Hospital Pharmacies
- 14.4.2. Retail Pharmacies
- 14.4.3. Others
- 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Supplement
- 14.6.2. By Application
- 14.6.3. By Distribution Channel
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company, 2018
- 15.3. Company Profiles
- 15.3.1. Zoetis
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Product Portfolio
- 15.3.1.3. SWOT Analysis
- 15.3.1.4. Strategic Overview
- 15.3.2. Boehringer Ingelheim International GmbH
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Product Portfolio
- 15.3.2.3. SWOT Analysis
- 15.3.2.4. Strategic Overview
- 15.3.3. Bayer AG
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Product Portfolio
- 15.3.3.3. SWOT Analysis
- 15.3.3.4. Strategic Overview
- 15.3.4. Equine Products UK LTD
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Product Portfolio
- 15.3.4.3. SWOT Analysis
- 15.3.4.4. Strategic Overview
- 15.3.5. Purina Animal Nutrition LLC.
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Product Portfolio
- 15.3.5.3. SWOT Analysis
- 15.3.5.4. Strategic Overview
- 15.3.6. Vetoquinol S.A.
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Product Portfolio
- 15.3.6.3. SWOT Analysis
- 15.3.6.4. Strategic Overview
- 15.3.7. Kentucky Equine Research
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Product Portfolio
- 15.3.7.3. SWOT Analysis
- 15.3.7.4. Strategic Overview
- 15.3.8. Plusvital Limited
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Product Portfolio
- 15.3.8.3. SWOT Analysis
- 15.3.8.4. Strategic Overview
- 15.3.9. Lallemand Inc.
- 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.9.2. Product Portfolio
- 15.3.9.3. SWOT Analysis
- 15.3.9.4. Strategic Overview
- 15.3.10. Virbac
- 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.10.2. Product Portfolio
- 15.3.10.3. SWOT Analysis
- 15.3.10.4. Strategic Overview